Navigation Links
NuVasive to Present at ThinkEquity Partners 5th Annual Growth Conference
Date:9/13/2007

SAN DIEGO, Sept. 13 /PRNewswire-FirstCall/ -- NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that Keith Valentine, President and Chief Operating Officer, and Kevin O'Boyle, Executive Vice President and Chief Financial Officer, are scheduled to present at the ThinkEquity Partners 5th Annual Growth Conference at the St. Regis Hotel, in San Francisco, CA on Monday, September 17, 2007 at 9:00 a.m. PT.

A live Web cast of the presentation will be available online from the investor relations page of the Company's corporate Web site at http://www.nuvasive.com. After the live Web cast, the presentation will remain available on NuVasive's Web site, http://www.nuvasive.com, for 30 days.

About NuVasive

NuVasive is a medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders. The Company's product portfolio is focused on applications in the over $3.6 billion U.S. spine fusion market. The Company's current principal product offering includes a minimally disruptive surgical platform called Maximum Access Surgery, or MAS(TM), as well as a growing offering of cervical and motion preservation products.

The MAS platform offers advantages for both patients and surgeons such as reduced surgery and hospitalization time and faster recovery. MAS combines three categories of current product offerings: NeuroVision(R) a proprietary software-driven nerve avoidance system; MaXcess(R) a unique split-blade design retraction system; and specialized implants, like SpheRx(R) and CoRoent(R), that collectively minimize soft tissue disruption during spine surgery while allowing maximum visualization and surgical reproducibility. NuVasive's product offering is also focused on cervical in
'/>"/>

SOURCE NuVasive, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
2. Researchers Present Ways To Reduce The Risk Of Dementia
3. Researchers Present Data Regarding The Efficiency Of Herbs
4. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
5. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
6. Drug Reactions First Present Themselves In The Mouth
7. Reminiscing Into The Past Makes You Dissatisfied With The Present
8. Living In The Past Indicates Dissatisfaction With Present
9. Movies Represent Coma In A Wrong Way
10. Onchocerciasis: Presentation And Treatment
11. Researchers Warn That Routine Physical Examination Could Miss Breech Presentation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...d to academic achievement, study finds , ...diovascular system in young adulthood may boost br... overall success later in life, new research sugge...ow (or should know) the benefits of exercise and i...study, appearing in this week,s online issue of th...
(Date:12/1/2009)... For many employers, the issue of ... just an employee benefit, it,s providing for the ...ores, Inc. is leading this effort, with the help o...ness center at its corporate offices, bringing qua...to employees and their dependents. ,, Beginn...
(Date:12/1/2009)... US Farms, Inc., (OTC: US... Wellness products is pleased to announce it has s...ia Micro-Lending Institution: Angels In Action ( w...rms, Inc. stated, "We are pleased to announce this...tilizing our Aloe365.com product line. We are dedi...
(Date:12/1/2009)... Gooooooaaaaaal! Cuties® C...2009/2010 growing season with a fresh starting lin...s, soccer. Joy Fawcett - an award-winning soccer ...fforts to celebrate and mentor moms on the sidelin...pansion into Texas and a community-based Web site ...
(Date:12/1/2009)...en may up chances of disease, study finds , ...ms may actually boost the risk of breast cancer in...Dutch researchers analyzed six previously publishe...adiation exposure from mammography among women wit... and two looking at the effect of radiation from s...
Breaking Medicine News(10 mins):Health News:Exercise May Lead to a Smarter, More Successful You 2Health News:Exercise May Lead to a Smarter, More Successful You 3Health News:Hobby Lobby Selects Concentra to Open Health Center 2Health News:Hobby Lobby Selects Concentra to Open Health Center 3Health News:US Farms, Inc. Announces Marketing Agreement With Micro Lending Institution Angels In Action 2Health News:US Farms, Inc. Announces Marketing Agreement With Micro Lending Institution Angels In Action 3Health News:Olympic Gold Medalist, World Cup Champion and Soccer Hall of Famer Joy Fawcett Sports A New Uniform as an Official Cuties(R) California Mandarin and Clementine Spokes-Mom 2Health News:Olympic Gold Medalist, World Cup Champion and Soccer Hall of Famer Joy Fawcett Sports A New Uniform as an Official Cuties(R) California Mandarin and Clementine Spokes-Mom 3Health News:Olympic Gold Medalist, World Cup Champion and Soccer Hall of Famer Joy Fawcett Sports A New Uniform as an Official Cuties(R) California Mandarin and Clementine Spokes-Mom 4Health News:Mammograms May Boost Cancer Risk in High-Risk Women 2
...tion Extends Pace,s Laboratory Network to the West...vices, Inc.,(Pace Analytical) is pleased to announ...al Services, Inc., has purchased the assets of Lau...RCRA and CWA programs. For more than 100 years, La...
... women in Iowa are much more likely to suffer from...rparts, a new University of Iowa study shows. , I...unties, UI psychologist Lisa Segre found that 40 p...ent of new mothers with a household income of $80,...
...go hospital one of 5 percent in the nation to rece... American Nurses,Credentialing Center (ANCC) has a...designation for its excellence in nursing practice... standard,in nursing excellence., (Photo: http:/...
...s show patients live average of 4 years longer tha...ESDAY, Feb. 19 (HealthDay News) -- The lack of a c...ssive brain tumor respond better to a new treatmen.... A study of 25 people with the condition showed t...
...HILL, N.C., Feb. 19 With sales forces shrinking,a...ooling to the constant,demand for rep time, winnin...ore challenging. In response, leading pharma compa... to recent,research from pharmaceutical benchmarki...
...HERSBURG, MD February 19, 2008 A recent survey o...ined current attitudes and practices when caring f..., revealed that most respondents (70 percent) feel...was sponsored by MedImmune, Inc. , The incidence ...
Other Medicine News:Health News:Pace Analytical Services, Inc., Purchases Laucks Testing Laboratory, Inc. 2Health News:Study: low-income women more likely to suffer from postpartum depression 2Health News:Study: low-income women more likely to suffer from postpartum depression 3Health News:Sharp Memorial Hospital Achieves Highest Honor for Nursing Excellence 2Health News:Missing Chromosome Improves Response to Brain Tumor Treatment 2Health News:Building an Effective Sales Force to Serve the U.S. Hospital Market 2Health News:Neonatologists and pediatricians highlight progress and barriers to preemie care 2Health News:Neonatologists and pediatricians highlight progress and barriers to preemie care 3
(Date:12/1/2009)..., Dec. 1 Micromet, Inc. ...loping novel, proprietary antibodies for the treat...es today announced that Bayer Schering Pharma AG h...ation and license agreement entered into on Januar...treatment of solid tumors. ,, Under the terms o...
(Date:11/30/2009)...ov. 30 DATATRAK Internat...es company focused on global eClinical solutions f...hat PFC Pharma Focus AG (PFC) has joined its CRO C...ontract for DATATRAK,s CRO partner training and of... suite. In addition, PFC will also have access to...
(Date:11/30/2009).... 30 Breast-Specific Gamma Imaging... of malignant or high-risk lesions in patients wit... according to results of a multicenter study prese...al Society of North America (RSNA). ,, In this ...nct diagnostic imaging modality at four institutio...
Breaking Medicine Technology:Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 2Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 3Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 4PFC Pharma Joins DATATRAK's CRO Connect Program 2PFC Pharma Joins DATATRAK's CRO Connect Program 3PFC Pharma Joins DATATRAK's CRO Connect Program 4BSGI Makes Significant Impact on Detection of Breast Cancer in Patients with Negative Mammographic Findings 2Brain Injury Association of New York State to Host Kick Off Cocktail Reception 56138 1Brain Injury Association of New York State to Host Kick Off Cocktail Reception 56138 2Helix Biopharma to Present at the Rodman 26 Renshaw 11th Annual Healthcare Conference 13831 1Helix Biopharma to Present at the Rodman 26 Renshaw 11th Annual Healthcare Conference 13831 2Helix Biopharma to Present at the Rodman 26 Renshaw 11th Annual Healthcare Conference 13831 3Dominion Diagnostics to Host Open House Reception in New Vermont Laboratory Facility 56131 1Dominion Diagnostics to Host Open House Reception in New Vermont Laboratory Facility 56131 2
...daq: MEDX ) today announced preliminary data from...evelopment code of Ono Pharmaceutical Co.,Ltd.), a...om patients with,recurrent or treatment-refractory...ity and pharmacokinetic profile of single-dose MDX...umor activity was observed,including one patient w...
...eting - - Conference call to be hosted Wednesday,... discuss results -, BRANFORD, Conn., June 1 C...d encouraging results from the ongoing Phase,I/II ...table Stage III or,Stage IV melanoma. The results ...estigator, and Professor, Chairman, Dept. of Melan...
Other Medicine Technology:Preliminary Data from Ongoing Phase 1 Data of Investigational Anti-PD-1 Antibody Presented at American Society of Clinical Oncology Annual Meeting 2Preliminary Data from Ongoing Phase 1 Data of Investigational Anti-PD-1 Antibody Presented at American Society of Clinical Oncology Annual Meeting 3Preliminary Data from Ongoing Phase 1 Data of Investigational Anti-PD-1 Antibody Presented at American Society of Clinical Oncology Annual Meeting 4CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma 2CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma 3CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma 4CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma 5CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma 6
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
Medicine Products: